Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Journal of Endourology|September 30, 2005
Long-term outcome of hand-assisted laparoscopic radical nephrectomy for localized stage T1/T2 renal-cell carcinomaMasahiko Harano, Masatoshi Eto, Kazuya Omoto, et al.Urology|March 22, 2008
Efficacy of short-term androgen deprivation with high-intensity focused ultrasound in the treatment of prostate cancer in JapanMakoto Sumitomo, Mutsuo Hayashi, Tetsuya Watanabe, et al.BJU International|May 19, 2015
Actions of cAMP on calcium sensitization in human detrusor smooth muscle contractionMaya Hayashi, Shunichi Kajioka, Momoe Itsumi, et al.Cancer Chemotherapy and Pharmacology|December 25, 2014
A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancerKazuhiro Suzuki, Seiichiro Ozono, Akito Yamaguchi, et al.Journal of Endourology|May 17, 2011
Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global StudyAkito Yamaguchi, Andreas Skolarikos, Niels-Peter Noor Buchholz, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|June 12, 2009
Changes in prostate volume in Japanese patients with benign prostatic hyperplasia: association with other urological measures and risk of surgical interventionTaiji Tsukamoto, Naoya Masumori, Haruo Nakagawa, et al.World Journal of Urology|November 28, 2014
Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPANMikio Sugimoto, Hiromi Hirama, Akito Yamaguchi, et al.Japanese Journal of Clinical Oncology|March 17, 2004
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patientsHideyuki Akaza, Akito Yamaguchi, Tadashi Matsuda, et al.Japanese Journal of Clinical Oncology|June 22, 2014
The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancerMasaki Shiota, Akira Yokomizo, Takumi Adachi, et al.Japanese Journal of Clinical Oncology|March 30, 2012
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancerSeiichiro Ozono, Takeshi Ueda, Senji Hoshi, et al.Pageof 5